Targacept Announces Participation in Upcoming Conferences

  Targacept Announces Participation in Upcoming Conferences

Needham Healthcare Conference 2013 Deutsche Bank dbAccess Healthcare
Conference 2013 Jefferies Global Healthcare Conference 2013

Business Wire

WINSTON-SALEM, N.C. -- April 22, 2013

Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company
developing novel NNR Therapeutics™, today announced that Dr. Stephen A. Hill,
President and Chief Executive Officer, is scheduled to present at the
following conferences:

  *12^th Annual Needham Healthcare Conference at the Westin Grand Central
    Hotel in New York, New York on Tuesday, April 30, 2013 at 12:10 p.m.
    Eastern Time.
  *38^th Annual Deutsche Bank dbAccess Healthcare Conference at the Westin
    Boston Waterfront in Boston, Massachusetts on Wednesday, May 29, 2013 at
    11:20 a.m. Eastern Time.
  *Jefferies 2013 Global Healthcare Conference at the Grand Hyatt Hotel in
    New York, New York on Thursday, June 6, 2013 at 1:00 p.m. Eastern Time.

Each presentation will be webcast and accessible from the Investor Relations
page of Targacept’s website, www.targacept.com. To ensure a timely connection
to any of the webcasts, it is recommended that users register at least 15
minutes prior to the scheduled start time. An archived version of each webcast
will be available for replay on the Investor Calendar section of the Investor
Relations page of Targacept’s website for at least two weeks following the
corresponding event.

About Targacept

Targacept is developing a diverse pipeline of innovative NNR Therapeutics™ for
difficult-to-treat diseases and disorders of the nervous system. NNR
Therapeutics selectively modulate the activity of specific neuronal nicotinic
receptors, unique proteins that regulate vital biological functions that are
impaired in various disease states. Targacept’s clinical pipeline includes
multiple Phase 2 product candidates, all representing first-in-class
opportunities. Targacept leverages its scientific leadership and diverse
pipeline to attract significant collaborations with global pharmaceutical
companies. For more information, please visit www.targacept.com.

TARGACEPT
Building Health, Restoring Independence®

Contact:

Targacept, Inc.
Alan Musso, 336-480-2186
SVP, Finance and Administration and CFO
alan.musso@targacept.com
or
Linnden Communications
Michelle Linn, 508-362-3087
linnmich@comcast.net
 
Press spacebar to pause and continue. Press esc to stop.